Target intelligence / Profile preview

Bile acids and other anionic gut lumen solutes

Molecular classification
Small molecule, Steroid derivative, Metabolite
01

Overview

Bile acids are steroid-based molecules synthesized from cholesterol in the liver and secreted into the duodenum to facilitate the emulsification and absorption of dietary lipids and fat-soluble vitamins. Beyond their detergent-like properties, they serve as critical signaling molecules that regulate metabolic pathways by activating receptors such as the Farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor (TGR5). In the context of pharmacology, the bile acid pool in the gut lumen is targeted by sequestrants to interrupt enterohepatic circulation. This interruption is a primary therapeutic strategy for managing hypercholesterolemia, as it forces the liver to utilize systemic cholesterol for de novo bile acid synthesis. Additionally, sequestering these anionic solutes is effective in treating bile acid malabsorption and the pruritus associated with cholestatic liver diseases. While highly effective for lipid management, these interventions can interfere with the absorption of other anionic drugs and essential nutrients.

Other names
Bile saltsIntestinal bile acidsAnionic intestinal solutesConjugated bile acids
02

Mechanism of action

Bile acid sequestrants are non-absorbed, positively charged resins that bind to negatively charged bile acids and other anionic solutes in the intestinal lumen through ion exchange. This binding forms an insoluble complex that is excreted in the feces, preventing the reabsorption of bile acids via the enterohepatic circulation. The resulting depletion of the bile acid pool triggers the liver to upregulate the conversion of endogenous cholesterol into new bile acids, thereby lowering systemic LDL cholesterol levels.

03

Biological functions

Lipid digestionCholesterol homeostasisSignal transductionMicelle formationAntimicrobial activity
04

Disease associations

HypercholesterolemiaBile acid malabsorptionPruritusCholestasisType 2 diabetes
05

Safety considerations

Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distress (constipation, bloating, flatulence)Drug-drug interactions (binding and reducing absorption of co-administered medications)Hypertriglyceridemia
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

Serum 7α-hydroxy-4-cholesten-3-one (C4)Fecal bile acid excretionLow-density lipoprotein (LDL) cholesterolFibroblast growth factor 19 (FGF19)

Beyond the preview

Go deeper on Bile acids and other anionic gut lumen solutes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile acids and other anionic gut lumen solutes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call